Agenda - Day 1
Patient Engagement Solutions & Innovations World Congress 2026 Europe
Transforming Care Through Technology, Empathy, and Collaboration.
London, United Kingdom
Day 1 - Thursday 26th March 2026
SCALING PATIENT ENGAGEMENT FOR MEASURABLE IMPACT
- What frameworks successfully integrate engagement into R&D, commercial, and medical functions?
- How can organizations operationalize engagement as a strategic business capability?
- What governance models ensure consistency across markets and therapeutic areas?
- Which KPIs demonstrate success across enterprise-level engagement programs?
Moderator:
Clara Bentham, Head of Corporate Affairs UK and Ireland, Sanofi
Panellists:
Nikul Bakshi, Research Involvement Lead, Parkinson’s UK
- How can pharmaceutical companies effectively embed patient input into every stage of the product lifecycle?
- What organizational structures or roles are most effective in championing patient engagement?
- How can agile and co-creation models be utilized to accelerate innovation in a patient-centric framework?
- What types of partnerships are most valuable in creating measurable value during real-world implementation of these models?
David Gillen, Chief Medical Officer, Norgine
- What outcome-based indicators effectively measure patient engagement success?
- How can data-driven dashboards link engagement to clinical and economic results?
- How do we monetize engagement outcomes without compromising ethics?
- What ROI models resonate most with executives and investors?
Derick Mitchell, Executive Director, PFMD
- How can global frameworks adapt to local health systems and cultures?
- What governance ensures compliance while enabling flexibility?
- How can digital platforms localize content without fragmenting experience?
- Which markets are setting the benchmark for scalable patient engagement?
Dani Motchi, CEO, IAPO (International Alliance of Patients’ Organizations)
- How patient co-creation can evolve from superficial input to a genuine partnership?
- What tools are available to support the rapid prototyping and testing of engagement solutions?
- How cross-functional teams can effectively apply design thinking at scale?
- What the measurable business outcomes of co-creation programs typically are?
- What collaboration models best unite pharma, payers, providers, and tech partners?
- How can joint platforms accelerate engagement innovation?
- What contractual and data frameworks best facilitate shared success metrics?
- How multi-stakeholder alliances can scale patient impact globally.
- What collaboration models best unite pharma, payers, providers, and tech partners?
- How can joint platforms accelerate engagement innovation?
- What contractual and data frameworks best facilitate shared success metrics?
- How multi-stakeholder alliances can scale patient impact globally.
Victoria Hayes, Director Public Affairs, Northern Cluster, Kyowa Kirin
ENABLING CONNECTED, PERSONALIZED & INTELLIGENT SOLUTIONS
- How engagement tools, wearables, and EHRs can be harmonized effectively?
- Architectural frameworks that support interoperability and secure data exchange within such ecosystems.
- How integrated platforms can mitigate patient friction and reduce data redundancy?
- Sustainable business models that support these ecosystems long-term.
- Proven AI solutions that enhance patient engagement and adherence.
- How predictive models can personalize interventions while respecting patient privacy?
- Strategies for ensuring human oversight and accountability in AI programs.
- Regulatory and ethical guardrails that apply to AI in patient engagement.
- Can blockchain address transparency and data ownership concerns?
- How blockchain can streamline compliance processes while simultaneously safeguarding data integrity?
- What barriers stand in the way of implementation?
- Effective strategies for communicating its advantages to patients.
Dr. Helen Bulbeck, Director of Services & Policy, brainstrust
- Combining digital tools with human support to guide people through complex care pathways
- Supporting people with low digital confidence and diverse needs
- Connecting patients and carers and building a safe online community for lived-experience support
- Strategies for ensuring trust and engagement in digital and hybrid support services
- Practical lessons for designing, delivering, and sustaining patient-centred services
- Turning co-created patient information into resources that people actually use
Melanie Costin, Director, Patient Engagement & Support, Fight Bladder Cancer
- How an end-to-end approach—combining digital diagnostics (M-PREG) with mechanistically targeted therapeutics (MZe786)—can transform the early detection, risk-stratification, and treatment of preeclampsia.
- Lessons from developing and integrating a full diagnostic-to-therapeutic pathway, including biomarker science, algorithm validation, real-world implementation, and translational drug development.
May Rezai, Chief Operations Officer, MirZyme Therapeutics
- Critical intersection of technological advancements and the indispensable need for human empathy in various fields
- Delve into real-world examples of compassionate digital care illustrating how technology can be leveraged to enhance, rather than diminish, genuine human connection and support
- Provider perspectives on the challenges of engaging individuals in a digitally-driven environment, offering valuable insights into overcoming these hurdles
- How to effectively integrate innovation with empathy to create more impactful and human-centered solutions.
6:15 - 7:15 pm - NETWORKING DRINK RECEPTION
